Custom service

PNA Backbone Modification

Modify the pna backbone to tune affinity, solubility or cell uptake

Turnaround: 4–7 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: miniPEG and lysine backbone insertion; charged backbone variants for solubility; conjugation-handle installation on PNA

The service is built around miniPEG and lysine backbone insertion. Depending on the molecule we may move to charged backbone variants for solubility or conjugation-handle installation on PNA to improve stability, loading or yield, and every batch is released with modified PNA oligomer with HPLC and MS QC.

Because PNA Backbone Modification projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Diagnostics where duplex Tm must be precisely tuned

Cell-uptake studies on modified PNA chemotypes

Clinical-grade PNA drug substance

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • MiniPEG and lysine backbone insertion as the default route, with charged backbone variants for solubility held as a proven fallback
  • Conjugation-handle installation on PNA worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Modified PNA oligomer with HPLC and MS QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — miniPEG and lysine backbone insertion, charged backbone variants for solubility — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Modified PNA oligomer with HPLC and MS QC is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
4–7 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
miniPEG and lysine backbone insertion; charged backbone variants for solubility; conjugation-handle installation on PNA
Deliverable
Modified PNA oligomer with HPLC and MS QC
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.